Cart
sales@molnova.com
CAY10784
CAS No. 1245814-52-1
CAY10784( —— )
Catalog No. M34813 CAS No. 1245814-52-1
CAY10784 (STAT3-IN-17) is a STAT3 inhibitor with antiproliferative and antitumor activities. CAY10784 showed antibacterial activity against Clostridium difficile.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 202 | In Stock |
|
| 10MG | 353 | In Stock |
|
| 25MG | 748 | In Stock |
|
| 50MG | 1172 | In Stock |
|
| 100MG | 1841 | In Stock |
|
| 200MG | 2539 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCAY10784
-
NoteResearch use only, not for human use.
-
Brief DescriptionCAY10784 (STAT3-IN-17) is a STAT3 inhibitor with antiproliferative and antitumor activities. CAY10784 showed antibacterial activity against Clostridium difficile.
-
DescriptionSTAT3-IN-17 is a moderate STAT3 inhibitor (IC50=0.7 μM; HEK-Blue IL-6), with antiproliferative activity in HeLa cells. STAT3-IN-17 has good pharmacokinetic characteristics. STAT3-IN-17 also inhibits pyruvate-ferredoxin oxidoreductase (PFOR), and inhibits Helicobacter pylori.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorSTAT | Antibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1245814-52-1
-
Formula Weight317.24
-
Molecular FormulaC11H6F3N3O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C1=CC=C(C(F)(F)F)C=C1)NC2=NC=C([N+]([O-])=O)S2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lü Z, et al. Structure-Activity Study of Nitazoxanide Derivatives as Novel STAT3 Pathway Inhibitors. ACS Med Chem Lett. 2021 Apr 1;12(5):696-703. ?
molnova catalog
related products
-
Corosolic acid
Corosolic acid contains anti-angiogenic activity that can suppress FAK signaling induced by angiopoietin-1.
-
STAT5 inhibitor 17f
A novel potent, selective inhibitor of phosphorylation and transcriptional activity of STAT5, but not STAT3, AKT, or Erk1/2 phosphorylation.
-
KI16
KI16 is a novel small molecules that inhibit STAT3-dependent transcription and function.
